Skip to main content
Clinical Trials/NCT05271396
NCT05271396
Completed
N/A

Respiratory Functions and Respiratory Muscle Strength in Patients With Temporomandibular Joint Dysfunction

Halic University1 site in 1 country46 target enrollmentAugust 6, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Temporomandibular Joint Dysfunction Syndrome
Sponsor
Halic University
Enrollment
46
Locations
1
Primary Endpoint
FEV1 (liter)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

In our study, it was aimed to evaluate respiratory functions and respiratory muscle strength in patients diagnosed with temporomandibular dysfunction (TMD) and to compare them with healthy individuals. The study was conducted with a total of 46 participants, 23 of whom were diagnosed with TMD and 23 healthy individuals, at Batman Training and Research Hospital between August 2021 and December 2021. In the evaluation, the demographic information and clinical findings of the participants were recorded. Mandible movements were evaluated with a digital caliper. For TMJ, the Visual Analogue Scale (VAS) was used to measure the severity of pain at rest and during activity. Cervical lordosis and shoulder posture assessment was done by distance measurement. Fonseca Anamnestic Index was used for TMD severity classification. Spirometric measurement was performed to evaluate respiratory functions of all participants and intraoral pressure measurement was performed to determine respiratory muscle strength. Statistical analyzes were performed using the IBM SPSS Statistics 26 program. Significance level was accepted as p<0.05.

Detailed Description

In our study, it was aimed to evaluate respiratory functions and respiratory muscle strength in patients diagnosed with temporomandibular dysfunction (TMD) and to compare them with healthy individuals. The study was conducted with a total of 46 participants, 23 of whom were diagnosed with TMD and 23 healthy individuals, at Batman Training and Research Hospital between August 2021 and December 2021. In the evaluation, the demographic information and clinical findings of the participants were recorded. Mandible movements were evaluated with a digital caliper. For TMJ, the Visual Analogue Scale (VAS) was used to measure the severity of pain at rest and during activity. Cervical lordosis and shoulder posture assessment was done by distance measurement. Fonseca Anamnestic Index was used for TMD severity classification. Spirometric measurement was performed to evaluate respiratory functions of all participants and intraoral pressure measurement was performed to determine respiratory muscle strength. Statistical analyzes were performed using the IBM SPSS Statistics 26 program. Significance level was accepted as p\<0.05.

Registry
clinicaltrials.gov
Start Date
August 6, 2021
End Date
February 11, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Seda Saka

Director

Halic University

Eligibility Criteria

Inclusion Criteria

  • Volunteer to participate in the study.
  • To be diagnosed with TMD for the TMD group,
  • To be healthy according to WHO definition for healthy matched group
  • Being between the ages of 17-50.

Exclusion Criteria

  • Having any previous pulmonary disease.
  • To have experienced a TMD problem due to trauma.
  • Having covid-19 in the last 6 months.

Outcomes

Primary Outcomes

FEV1 (liter)

Time Frame: at the enrollment

This is the amount of air with pulmonary function test that the patient can force out of their lungs in one second.

FEV1 (%-percentage)

Time Frame: at the enrollment

This is the percentage of air with pulmonary function test that the patient can force out of their lungs in one second.

Inspiratory muscle test

Time Frame: at the enrollment

Maximal inspiratory pressure (MIP) is going to measured using a mouth pressure meter (MicroRPM; MicroMedical, UK) according to the guideline of ATS and European Respiratory Society (ERS).

FVC (liter)

Time Frame: at the enrollment

This is the greatest total amount of air patient can forcefully breathe out after breathing in as deeply as possible.

FEV1/FVC (percentage)

Time Frame: at the enrollment

The FEV1/FVC ratio is a number that represents the percentage of patient lung capacity patient is able to exhale in one second.

Expiratory muscle test

Time Frame: at the enrollment

Maximal expiratory pressure (MEP) is going to measured using a mouth pressure meter (MicroRPM; MicroMedical, UK) according to the guideline of ATS and European Respiratory Society (ERS).

Secondary Outcomes

  • Evaluation of Mandible Movements(at the enrollment)
  • Cervical Lordosis and Shoulder Posture Evaluation(at the enrollment)
  • Pain assessment(at the enrollment)
  • Temporomandibular joint dysfunction classification (Fonseca Index)(at the enrollment)

Study Sites (1)

Loading locations...

Similar Trials